Zytiga has received an award from the German Society of Urologists for being the most innovative product in oncology for 2012. Zytiga beat competitors Cialis and Xgeva to be recognised as the most significant development in the treatment of prostate cancer as judged by the urologists. The "Innovative Product 2012" (Das Inovativ Produkt 2012) award was presented to Gerd Czekalla of Jannsen-Cilag who received the award on behalf of the company which is the European branch of Johnson & Johnson who manufacture Zytiga.
http://www.youtube.com/watch?v=rL40cfdiyS4
No comments:
Post a Comment